Operating Bench · DN8 Partners

You closed the deal. The first 180 days decide whether it was a good one.

The seller walked out with the playbook in their head. The team is watching you. The lender wants reporting that never existed. We put a proven operator in the seat within 14 days, hit the agreed metric by day 180, and hand it back to your team. Not a consultant's deck. An operator in the chair, accountable for one number, with skin in the game.

Mandate 180
Function: Finance / FP&A
Agreed with the buyer
Metric: 13-week cash flow and lender-ready reporting
Operator in the seat: 14 days
Weekly board reporting
Handoff to your team: day 180
Accountability on DN8, not on you
6MUS businesses change hands by 2035
~1Mwill be sold, $5T in deals
60%of owners have no succession plan
14 daysto an operator in the seat
When you need us

Three moments when this gets bought without haggling

We don't sell improvements for later. We show up when the cost of doing nothing is measured in money today.

01

The first 180 days post-close

The seller is gone, the team is anxious, there is no reporting for the lender or the board. The window where the cost of a mistake is highest.

02

A founder or key leader exits

A function is decapitated, hiring a replacement takes 4-6 months, and decisions are needed tomorrow.

03

Preparing to sell

12-18 months before exit, hand-run operations must become a system, or the multiple drops.

Positioning

We don't advise. We take the seat, hit the number, and hand it back.

What we sell
  • A closed transition with an end date
  • An agreed metric and accountability for it
  • Speed: an operator in the seat in 14 days
  • Handoff and exit, not an endless retainer
  • Accumulated data on what works in companies like yours
What we don't sell
  • Hours and "expertise in general"
  • Strategy decks without execution
  • A permanent-hire search
  • Permanent presence and dependency on us
  • "Top people" claims with no numbers behind them
How it works

Three products: a cheap way in, the core mandate, a long tie

Diagnostic 14
The wedge

A 14-day, data-driven diagnostic of organization and execution risk. A dependency map and a first-180-days plan with metrics. Cheap, fast, no trust required up front.

from $15K
Mandate 180
Core product

An operator in the seat for one function, an agreed metric, weekly board reporting, handoff to your team by day 180.

$30K / mo + bonus
Bench Access
Fund subscription

Priority access to the bench for your whole portfolio, two diagnostics a year included, a fixed rate on mandates.

from $60K / yr
Equity component. On mandates where the buyer agrees, part of the fee can be swapped for equity in the company or carry participation. Deal flow turns into a portfolio of assets.
Why now

Two waves have collided

A record transfer of small and mid-sized business ownership, and buyers arriving without operational depth: independent sponsors and searchers. They have capital and an investor mandate, but no operating bench. Funds this size don't keep operating partners on staff, the economics don't allow it. The window is 3-6 years, before big consulting firms and fund platforms move down into this segment.

How we're different

We don't say "we have top operators." We speak in numbers.

After the first mandates: how many closed, the median metric movement, the share handed off on time. That is the only claim a competitor can't copy with a press release. Our way in is a 14-day, data-driven diagnostic of your people and organization: it shows what you didn't see in the data room, where the execution risk in the acquired company actually sits.

Who it's for

For owners of portfolios of companies

Independent sponsors Searchers post-close Small private equity Family offices with direct deals
Let's talk

Just closed? Or about to?

A 30-minute call and a read on where your execution risk actually sits. No obligation.

© 2026 · dn8.partners